• Earlier this month, Costco Wholesale’s partner SCAN Group launched Costco-branded Medicare Advantage and supplement plans in select states, extending the retailer’s reach into the Medicare insurance market and linking coverage to Costco’s existing pharmacy, vision, hearing, and over-the-counter services.
• This move gives Costco a new way to deepen relationships with its aging membership base and tap into the very large Medicare market beyond its core warehouse operations.
• Next, we’ll examine how Costco’s entry into Medicare insurance through SCAN could reshape its membership-led growth narrative and earnings mix.

Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Costco Wholesale Investment Narrative Recap

To own Costco, you have to believe its membership model, disciplined expansion, and tight cost control can justify a premium valuation even as revenue growth trails the broader US market. The SCAN Medicare launch broadens Costco’s service ecosystem, but the near term share price catalyst still looks tied more to warehouse openings, e-commerce growth, and the September 24 earnings report. Key risks remain elevated labor and supply chain costs, which could pressure margins if cost inflation persists.

Among recent announcements, the expansion of Costco’s Instacart partnership into France and Spain stands out alongside the SCAN news, because both extend the value of membership beyond the physical warehouse. While Medicare plans target older members, faster same day delivery and richer digital offerings cater to broader demographics, supporting traffic and membership-fee resilience. Together, these moves could influence how investors think about Costco’s growth drivers beyond traditional US store openings.

Yet for all this good news, investors should also be aware of rising labor costs and how they could eventually...

Costco Wholesale's narrative projects $363.2 billion revenue and $11.6 billion earnings by 2029. This requires 7.4% yearly revenue growth and a $2.8 billion earnings increase from $8.8 billion today.

Uncover how Costco Wholesale's forecasts yield a $1083 fair value, a 14% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling Costco at about US$376.8 billion in revenue and US$12.6 billion in earnings by 2029, so if you believe membership strength and digital engagement will accelerate even faster after the SCAN Medicare launch, your view may be closer to that bullish camp than the consensus, highlighting how differently reasonable investors can see the very same stock.

Explore 17 other fair value estimates on Costco Wholesale - why the stock might be worth as much as 39% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Costco Wholesale research is our analysis highlighting 2 key rewards that could impact your investment decision.
• Our free Costco Wholesale research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Costco Wholesale's overall financial health at a glance.

Looking For Alternative Opportunities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The latest GPUs need a type of rare earth metal called Terbium and there are only 28 companies in the world exploring or producing it. Find the list for free.
• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.